| 000 | 01879 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516064658.0 | ||
| 264 | 0 | _c20120404 | |
| 008 | 201204s 0 0 eng d | ||
| 022 | _a1423-0240 | ||
| 024 | 7 |
_a10.1159/000334063 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJacobs, Volker R | |
| 245 | 0 | 0 |
_aComparison of actual hospital costs versus DRG revenues for in-patient treatment of febrile neutropenia during adjuvant anthracycline plus/minus taxane-based chemotherapy for primary breast cancer. _h[electronic resource] |
| 260 |
_bOnkologie _c2011 |
||
| 300 |
_a614-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnthracyclines |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xeconomics |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xeconomics |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aBridged-Ring Compounds _xeconomics |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 |
_aDiagnosis-Related Groups _xeconomics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFever _xdrug therapy |
| 650 | 0 | 4 |
_aGermany _xepidemiology |
| 650 | 0 | 4 |
_aHealth Care Costs _xstatistics & numerical data |
| 650 | 0 | 4 |
_aHospitalization _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIncome _xstatistics & numerical data |
| 650 | 0 | 4 |
_aInsurance, Health, Reimbursement _xeconomics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeutropenia _xdrug therapy |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 |
_aTaxoids _xeconomics |
| 700 | 1 | _aMayer, Stefanie C | |
| 700 | 1 | _aPaessens, Bernadette J | |
| 700 | 1 | _aBernard, Rudolf | |
| 700 | 1 | _aHarbeck, Nadia | |
| 700 | 1 | _aKiechle, Marion | |
| 700 | 1 | _aIhbe-Heffinger, Angela | |
| 773 | 0 |
_tOnkologie _gvol. 34 _gno. 11 _gp. 614-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000334063 _zAvailable from publisher's website |
| 999 |
_c21331262 _d21331262 |
||